Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Ophthalmic Surgery, Lasers & Imaging Retina|May 18, 2018
A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMDJohn A Wells, Christine R Gonzales, Brian B Berger, et al.
Retina (Philadelphia, Pa.)|June 3, 2015
RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPYSusan B Bressler, Michele Melia, Adam R Glassman, et al.
Translational Vision Science & Technology|December 23, 2021
Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular EdemaPravin U Dugel, Arshad M Khanani, Brian B Berger, et al.
American Journal of Ophthalmology|December 11, 2012
Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II studyPeter A Campochiaro, Roomasa Channa, Brian B Berger, et al.
Investigative Ophthalmology & Visual Science|November 8, 2012
Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomographyKakarla V Chalam, Susan B Bressler, Allison R Edwards, et al.
Ophthalmology|March 14, 2007
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema, Magdalena G Krzystolik, Samara F Strauber, et al.
JAMA|November 14, 2015
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial, Jeffrey G Gross, Adam R Glassman, et al.
Pageof 1